HOFA Announce New Digital Art Awards, in Collaboration with Exhibition Partner PhillipsX 10-04-2025, 19:03

SAP Fioneer launches tailored SME banking offering 22-06-2023, 14:36

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00